MVH
Matthew VANDER HEIDEN
Koch Institute for Integrative Cancer Research at MIT
Description
Matthew Vander Heiden is the Director of the Koch Institute for Integrative Cancer Research, the Lester Wolfe (1911) Chair in Molecular Biology, and a Professor in the Department of Biology at the Massachusetts Institute of Technology. He is also a practicing Medical Oncologist and Instructor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School, as well as an Institute Member of the Broad Institute of Harvard and MIT. Vander Heiden received his MD and PhD degrees from the University of Chicago, where he worked in the laboratory of Craig Thompson. He completed clinical training in internal medicine at the Brigham and Women’s Hospital and a Hematology-Oncology fellowship at the Dana-Farber Cancer Institute / Massachusetts General Hospital program. He was a post-doctoral fellow in the laboratory of Lewis Cantley at Harvard Medical School, where he was supported by the Damon Runyon Cancer Research Foundation. In 2010, Vander Heiden joined the MIT faculty. His laboratory studies how metabolism is regulated to meet the needs of cells in different physiological situations. A major focus of his research is the role of metabolism in cancer, and particularly how metabolic pathways support cancer cell proliferation and survival. Using a combination of biochemistry, molecular biology and mouse models, the aim of the Vander Heiden laboratory is to understand how metabolism influences different stages of tumor biology with a goal to improve cancer treatment in the clinic. He also serves on the scientific advisory boards of multiple cancer centers, as well as the investment advisory board and scientific advisory boards of multiple companies.
Loading